Literature DB >> 10562651

Histopathology of age-related macular degeneration.

W R Green1.   

Abstract

Age-related macular degeneration is a diffuse condition involving the retinal pigment epithelium, the photoreceptor cell layer, and perhaps the choriocapillaris. The early morphologic change is the development of basal deposits of two distinct types. This phase is not ophthalmoscopically detectable but psychophysical testing may demonstrate reduced function. The process becomes detectable with the occurrence of secondary changes in the pigment epithelium, soft drusen formation, and choroidal neovascularization. A reparative response results in disciform scars. The various morphologic forms of age-related macular degeneration are interrelated.

Entities:  

Mesh:

Year:  1999        PMID: 10562651

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  114 in total

1.  Clinicopathological correlation of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration.

Authors:  S Aisenbrey; B A Lafaut; S Reynders; P Szurman; S Grisanti; C Vanden Broecke; P Walter; K U Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-03-22       Impact factor: 3.117

Review 2.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

3.  Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease.

Authors:  Gonçalo R Abecasis; Beverly M Yashar; Yu Zhao; Noor M Ghiasvand; Sepideh Zareparsi; Kari E H Branham; Adam C Reddick; Edward H Trager; Shigeo Yoshida; John Bahling; Elena Filippova; Susan Elner; Mark W Johnson; Andrew K Vine; Paul A Sieving; Samuel G Jacobson; Julia E Richards; Anand Swaroop
Journal:  Am J Hum Genet       Date:  2004-02-16       Impact factor: 11.025

Review 4.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

5.  Treatment of dry age-related macular degeneration with dobesilate.

Authors:  P Cuevas; L A Outeiriño; J Angulo; G Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-06-21

6.  Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration.

Authors:  J L Duncan
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

7.  Inhibition of proliferation of retinal vascular endothelial cells more effectively than choroidal vascular endothelial cell proliferation by bevacizumab.

Authors:  Bharani Krishna Mynampati; Kumar Sambhav; Sandeep Grover; Kakarla V Chalam
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

8.  Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.

Authors:  G Malek; L V Johnson; B E Mace; P Saloupis; D E Schmechel; D W Rickman; C A Toth; P M Sullivan; C Bowes Rickman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-03       Impact factor: 11.205

9.  Effects of bevacizumab, ranibizumab, and aflibercept on phagocytic properties in human RPE cybrids with AMD versus normal mitochondria.

Authors:  Thomas A Vo; Sina Abedi; Kevin Schneider; Marilyn Chwa; M Cristina Kenney
Journal:  Exp Eye Res       Date:  2018-07-30       Impact factor: 3.467

Review 10.  Biochemical Measurements of Free Opsin in Macular Degeneration Eyes: Examining the 11-CIS Retinal Deficiency Hypothesis of Delayed Dark Adaptation (An American Ophthalmological Society Thesis).

Authors:  Anne Hanneken; Thomas Neikirk; Jennifer Johnson; Masahiro Kono
Journal:  Trans Am Ophthalmol Soc       Date:  2017-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.